Wird geladen...
Renal Failure among Multiple Myeloma patients utilizing Carfilzomib and Associated Factors in the ‘Real-World’
BACKGROUND: Carfilzomib, a next generation proteasome inhibitor, improves outcomes in patients with multiple myeloma (MM); however, a proportion of those treated develop renal failure due to adverse event, comorbidity, or myeloma progression. The rate of renal failure and associated risk factors rem...
Gespeichert in:
| Veröffentlicht in: | Ann Hematol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054467/ https://ncbi.nlm.nih.gov/pubmed/33475778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-021-04420-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|